Johnson & Johnson Announces U.S. Launch Of Shockwave C2 Aero Fly Coronary Catheter, Says It Halves Treatment Time
Share
Why It Matters
Johnson & Johnson released a new heart tool that cuts treatment time in half. When a company launches new products that work better, it can help grow their business.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.